Arvinas, Inc. (ARVN)
8.19
-0.21
(-2.50%)
USD |
NASDAQ |
Sep 15, 09:47
Arvinas 1 Year Total Returns (Daily) : 8.53% for Sept. 14, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 14, 2026 | 8.53% |
| September 11, 2026 | 8.19% |
| September 10, 2026 | 11.24% |
| September 09, 2026 | 9.50% |
| September 08, 2026 | 14.36% |
| September 04, 2026 | 23.39% |
| September 03, 2026 | 17.85% |
| September 02, 2026 | 21.39% |
| September 01, 2026 | 20.05% |
| August 31, 2026 | 19.02% |
| August 28, 2026 | 18.30% |
| August 27, 2026 | 14.36% |
| August 26, 2026 | 23.61% |
| August 25, 2026 | 28.34% |
| August 24, 2026 | 27.60% |
| August 21, 2026 | 28.29% |
| August 20, 2026 | 27.11% |
| August 19, 2026 | 35.57% |
| August 18, 2026 | 29.15% |
| August 17, 2026 | 29.76% |
| August 14, 2026 | 26.69% |
| August 13, 2026 | 27.08% |
| August 12, 2026 | 30.63% |
| August 11, 2026 | 36.52% |
| August 10, 2026 | 42.93% |
| Date | Value |
|---|---|
| August 07, 2026 | 40.22% |
| August 06, 2026 | 34.99% |
| August 05, 2026 | 10.38% |
| August 04, 2026 | 19.52% |
| August 03, 2026 | 8.63% |
| July 31, 2026 | 7.93% |
| July 30, 2026 | 9.50% |
| July 29, 2026 | 9.89% |
| July 28, 2026 | 7.75% |
| July 27, 2026 | 4.85% |
| July 24, 2026 | 1.77% |
| July 23, 2026 | 3.18% |
| July 22, 2026 | 8.97% |
| July 21, 2026 | 9.84% |
| July 20, 2026 | 9.12% |
| July 17, 2026 | 3.22% |
| July 16, 2026 | 5.80% |
| July 15, 2026 | 11.89% |
| July 14, 2026 | 5.08% |
| July 13, 2026 | 3.98% |
| July 10, 2026 | 4.82% |
| July 09, 2026 | 3.77% |
| July 08, 2026 | 6.73% |
| July 07, 2026 | 10.27% |
| July 06, 2026 | 6.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -25.95% |
| CNBX Pharmaceuticals, Inc. | -66.67% |
| GB Sciences, Inc. | 0.00% |
| Fulcrum Therapeutics, Inc. | -45.86% |
| Definium Therapeutics, Inc. | 326.4% |